Cours Puma Biotechnology Inc OTC Bulletin Board
Actions
PBYI
US74587V1070
Recherche biotechnologique et médicale
CA 2024 * | 219 M 198 M | CA 2025 * | 225 M 203 M | Capitalisation | 186 M 167 M |
---|---|---|---|---|---|
Résultat net 2024 * | 10 M 9,02 M | Résultat net 2025 * | 15 M 13,53 M | VE / CA 2024 * | 0,85 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 0,83 x |
PER 2024 * |
15,9
x | PER 2025 * |
15,8
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 84,6% |
Dernier transcript sur Puma Biotechnology Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/09/10 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 05/11/18 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/03/13 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 23/02/18 |
Jay Moyes
BRD | Director/Board Member | 70 | 27/04/12 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/09/10 |
Varia. 1 janv. | Capi. | |
---|---|---|
+43,36% | 54,64 Md | |
-5,31% | 39,92 Md | |
+37,52% | 38,82 Md | |
+14,75% | 26,86 Md | |
-12,56% | 26,22 Md | |
-22,45% | 18,78 Md | |
+25,12% | 12,21 Md | |
+0,04% | 12,16 Md | |
+26,04% | 11,94 Md |